General Information

Age Group

Adults

Status

Recruiting

Protocol Number

NCT05370820

Background Information

The study is designed to test the hypothesis that the same dose of TXA prior to delivery or pre-cord clamp will be sufficient to achieve hemorrhage prevention targets and define dosing schema for intravenous (IV) and intramuscular (IM).

For additional information, visit: https://clinicaltrials.gov/study/NCT05370820

Offered At

Inova Fairfax Medical Campus 
Department of Obstetrics and Gynecology
3300 Gallows Road
Falls Church, VA 22042 
Principal Investigator

Homa Ahmadzia, MD

Eligibility Information

  • Women who are undergoing medically indicated cesarean section at greater than 34+0 weeks gestation or women undergoing elective cesarean section at 39+0 weeks gestation
  • Women undergoing vaginal delivery at > 34+0 weeks gestation.
  • Pregnant women with normal serum creatinine (serum creatinine < 0.9)
  • Women between the ages of 18 and 50 years old

Ineligibility Information

  • Women with certain thrombotic disorders
  • Known renal or liver dysfunction
  • Twin or triplet pregnancies